Kimberly A. Selting

Veterinary <scp>Cooperative</scp> Oncology Group—Common Terminology Criteria for Adverse Events (<scp>VCOG‐CTCAE</scp> v2) following investigational therapy in dogs and cats

Amy K. LeBlanc, Matthew J. Atherton, R. Timothy Bentley et al. · Veterinary and Comparative Oncology · 2021 · 296 citations · Full text

Pathology, Veterinary Research, Investigational Therapy +18

Outcomes of Cats With Oral Tumors Treated With Mandibulectomy: 42 Cases

Nicole C. Northrup, Kimberly A. Selting, Kenneth M. Rassnick et al. · Journal of the American Animal Hospital Association · 2006 · 107 citations

Medical Records, Survival Rates, Medicine +8

Defining the Pharmacodynamic Profile and Therapeutic Index of NHS-IL12 Immunocytokine in Dogs with Malignant Melanoma

Melissa Paoloni, Christina Mazcko, Kimberly A. Selting et al. · PLoS ONE · 2015 · 64 citations · Full text

Gold Nanoparticle Based X-Ray Contrast Agent for Tumor Imaging in Mice and Dog: A Potential NanoPlatform for Computer Tomography Theranostics

Nripen Chanda, Anandhi Upendran, Evan Boote et al. · Journal of Biomedical Nanotechnology · 2013 · 42 citations

Nanoparticles, Engineering, Imaging Agent +17

Intraarticular injection of a Tin‐117 m radiosynoviorthesis agent in normal canine elbows causes no adverse effects

Jimmy C. Lattimer, Kimberly A. Selting, Joni Lunceford et al. · Veterinary Radiology & Ultrasound · 2019 · 21 citations